| Literature DB >> 30143011 |
Xiaobo Zhu1,2, Yao Yao2, Chen Yao1, Qing Jiang3,4.
Abstract
BACKGROUND: Deep vein thrombosis (DVT) is one of the most dangerous complications of total joint arthroplasty (TJA). Systemic inflammation has proved to have a great contribution to thrombosis and has been considered as a risk factor for DVT recently. The lymphocyte to monocyte ratio (LMR) and monocyte to high-density lipoprotein (HDL) ratio (MHR) are two biomarkers used widely for systemic inflammation. This study aims to find out the potential predictive value of LMR and MHR for DVT after TJA.Entities:
Keywords: Deep vein thrombosis; Lymphocyte to monocyte ratio; Monocyte to HDL ratio; Total joint arthroplasty
Mesh:
Substances:
Year: 2018 PMID: 30143011 PMCID: PMC6109316 DOI: 10.1186/s13018-018-0910-2
Source DB: PubMed Journal: J Orthop Surg Res ISSN: 1749-799X Impact factor: 2.359
Characteristic data of subjects
| Variables | Total patients | Total patients | ||||
|---|---|---|---|---|---|---|
| Without DVT ( | With DVT ( | Without symptom ( | With symptom ( | |||
| Age (years) | 63.5 ± 13.8 | 67.7 ± 10.3 | 0.001 | 64.0 ± 12.9 | 65.6 ± 12.2 | 0.358 |
| Gender (female) | 509(70%) | 99(78.6%) | 0.05 | 559(70.3%) | 49(84.5%) | 0.021 |
| BMI | 24.5 ± 4.4 | 25.5 ± 4.5 | 0.018 | 24.6 ± 4.4 | 26.8 ± 3.7 | < 0.001 |
| Hypertension | 282(38.8%) | 56(44.4%) | 0.231 | 313(39.4%) | 25(43.1%) | 0.575 |
| Insulin resistance | 96(13.2%) | 17(13.5%) | 0.93 | 102(12.8%) | 11(19.0%) | 0.183 |
| Smoking history | 69(9.5%) | 6(4.8%) | 0.084 | 72(9.1%) | 4(6.9%) | 0.577 |
| Heart disease | 64(8.8%) | 8(6.3%) | 0.36 | 66(8.3%) | 6(10.3%) | 0.589 |
| Malignancy | 26(2.2%) | 8(6.3%) | 0.009 | 29(3.6%) | 5(8.6%) | 0.062 |
| Thrombosis history | 75(10.3%) | 10(7.9%) | 0.408 | 79(9.9%) | 6(10.3%) | 0.920 |
P < 0.05 was considered statistically significant
Perioperative laboratory data of patients
| Variables | Total patients | Total patients | ||||
|---|---|---|---|---|---|---|
| Without DVT ( | With DVT ( | Without symptomatic DVT ( | With symptomatic DVT ( | |||
| Preoperative data | ||||||
| RBC(× 1012/L) | 4.3 ± 0.5 | 4.2 ± 0.5 | 0.402 | 4.3 ± 0.5 | 4.2 ± 0.5 | 0.426 |
| Hb (g/L) | 127.8 ± 15.3 | 128.2 ± 14.8 | 0.79 | 128.0 ± 15.2 | 124.5 ± 13.8 | 0.080 |
| WBC(× 109/L) | 6.0 ± 1.7 | 6.0 ± 2.1 | 0.825 | 6.0 ± 1.8 | 5.9 ± 1.5 | 0.78 |
| D-dimmer (mg/L) | 1.5 ± 3.5 | 1.5 ± 2.9 | 0.988 | 1.5 ± 3.4 | 1.5 ± 2.2 | 0.97 |
| Fibrinogen (g/L) | 3.3 ± 0.8 | 3.3 ± 0.8 | 0.562 | 3.4 ± 0.8 | 3.2 ± 0.8 | 0.19 |
| LMR | 5.9 ± 4.5 | 2.7 ± 1.8 | < 0.001 | 5.9 ± 4.8 | 2.8 ± 1.8 | < 0.001 |
| MHR | 0.3 ± 0.2 | 0.4 ± 0.4 | < 0.001 | 0.3 ± 0.2 | 0.4 ± 0.3 | < 0.001 |
| Postoperative data | ||||||
| RBC(×1012) | 3.6 ± 0.6 | 3.7 ± 1.0 | 0.072 | 3.7 ± 0.7 | 3.6 ± 1.1 | 0.597 |
| Hb (g/L) | 108.0 ± 16.1 | 110.9 ± 14.7 | 0.055 | 108.8 ± 16.1 | 103.9 ± 14.1 | 0.023 |
| WBC(×109/L) | 10.8 ± 3.4 | 10.5 ± 3.3 | 0.43 | 10.7 ± 3.4 | 11.1 ± 3.6 | 0.402 |
| D-dimmer (mg/L) | 2.9 ± 3.7 | 3.4 ± 5.8 | 0.159 | 2.2 ± 2.4 | 2.8 ± 2.0 | 0.063 |
| Fibrinogen (g/L) | 4.6 ± 0.98 | 4.3 ± 0.9 | < 0.001 | 4.6 ± 1.2 | 4.2 ± 0.8 | 0.032 |
| LMR | 4.2 ± 2.8 | 1.5 ± 2.2 | < 0.001 | 2.2 ± 1.0 | 1.3 ± 0.9 | < 0.001 |
| MHR | 0.4 ± 0.2 | 0.6 ± 0.5 | < 0.001 | 0.4 ± 0.26 | 0.8 ± 0.5 | < 0.001 |
P < 0.05 was considered statistically significant
Distribution of perioperative LMR and MHR between distal DVT and proximal DVT
| Variables | Distal DVT ( | Proximal DVT ( | |
|---|---|---|---|
| Preoperative | |||
| LMR | 5.8 ± 6.3 | 2.9 ± 1.9 | 0.09 |
| MHR | 0.3 ± 0.2 | 0.4 ± 0.2 | 0.01 |
| Postoperative | |||
| LMR | 4.7 ± 3.5 | 1.1 ± 0.7 | < 0.001 |
| MHR | 0.3 ± 0.2 | 0.7 ± 0.3 | < 0.001 |
P < 0.05 was considered statistically significant
Multiple logistic regression analyses for predictors of DVT or symptomatic DVT after adjustment
| Variables | Total DVT events | Variables | Symptomatic DVT events | ||
|---|---|---|---|---|---|
| OR(95%CI) | OR(95%CI) | ||||
| Age | 1.00(0.983~1.023) | 0.777 | BMI | 1.17(1.07~1.29) | 0.001 |
| BMI | 1.10(1.039~1.158) | 0.001 | Gender (Female) | 1.00(0.983~1.023) | 0.004 |
| Malignancy | 1.93(0.554~6.691) | 0.303 | LMR (pre-op) | 1.10(1.039~1.158) | 0.499 |
| LMR (pre-op) | 0.72(0.616~0.844) | < 0.001 | MHR (pre-op) | 1.93(0.554~6.691) | 0.008 |
| MHR (pre-op) | 0.72(0.274~1.895) | 0.506 | Hb (post-op) | 0.72(0.616~0.844) | 0.002 |
| Fibrinogen (post-op) | 0.87(0.651~1.169) | 0.36 | Fibrinogen (post-op) | 0.72(0.274~1.895) | 0.818 |
| LMR (post-op) | 0.32(0.236~0.424) | < 0.001 | LMR (post-op) | 0.87(0.651~1.169) | < 0.001 |
| MHR (post-op) | 1.63(0.636~4.186) | 0.309 | MHR (post-op) | 0.32(0.236~0.424) | 0.559 |
P < 0.05 was considered statistically significant
Fig. 1ROC curve of D-dimer, Hb, LMR, and MHR to predict DVT. The ROC curve analysis and AUC demonstrated the specificity and sensitivity of perioperative D-dimer, preoperative LMR, and postoperative Hb in predicting DVT were low. But the postoperative LMR had a high sensitivity and specificity to predict DVT
AUC of the ROC curve and 95% confidence interval of preoperative LMR, postoperative LMR, preoperative MHR, postoperative Hb, and perioperative D-dimer
| Variables | AUC | 95%CI | Sensitivity (%) | Specificity (%) | |
|---|---|---|---|---|---|
| Hb (post-op) | 0.55 | 0.52~0.58 | 0.073 | 44.4 | 68.8 |
| LMR (pre-op) | 0.78 | 0.75~0.81 | < 0.001 | 82.5 | 56.1 |
| MHR (pre-op) | 0.63 | 0.59~0.66 | < 0.001 | 95.2 | 25.5 |
| LMR (post-op) | 0.92 | 0.90~0.93 | < 0.001 | 83.3 | 87.9 |
| D-dimer (pre-op) | 0.53 | 0.49~0.56 | 0.35 | 39.7 | 72.2 |
| D-dimer (post-op) | 0.52 | 0.49~0.55 | 0.42 | 86.5 | 30.1 |
P < 0.05 was considered statistically significant